Comparison of chlorthalidone, propranolol and bopindolol in six-month treatment of arterial hypertension

International Journal of Clinical Pharmacology Research

Volumn 18, Issue 2, 1998, Pages 73-78

  Bagatin, J ^a   Sardelic S ^a   Pivac, N ^a   Polic, S ^a   Ljutic, D ^a   Rakic, D ^a   Naranca M ^a   Bojic, L ^a   Kovacic Z ^a   Rumboldt, Z ^a  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOPINDOLOL; CHLORTALIDONE; CHOLESTEROL; GLUCOSE; POTASSIUM ION; PROPRANOLOL; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL; UREA;

ADULT; ARTICLE; BIOCHEMISTRY; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELECTROLYTE BALANCE; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; CHLORTHALIDONE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; HYPOKALEMIA; LIPIDS; MALE; MIDDLE AGED; PINDOLOL; PROPRANOLOL; PROSPECTIVE STUDIES;

EID: 7844224766     PISSN: 02511649     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Leren P., Eide I., Foss D.P., et al. Antihypertensive drugs and blood lipids. The Oslo study. J. Cardiovasc. Pharmacol., 4 (Suppl 2), 222, 1982.
2. Curb D., Barhani N.O., Blasowski T.P., Limbaldi N., Fotin S., Williams W. Long-term surveillance for adverse effects of antihypertensive drugs. J.A.M.A., 253, 3263, 1985.
3. Knockel J.P. Diuretic induced hypokalemia. Am. J. Med., 77, 18, 1984.
4. Hollifield J.W., Slaton P.E. Thiazide-diuretics, hypokalemia and cardiac arrhythmias. Acta Med. Scand., 647, 67, 1981.
5. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The Fifth Report of the Joint National Committee on Detection. Evaluation and Treatment of High Blood Pressure (JNC V). Arch. Intern. Med., 153, 154, 1993.
6. Vrtiovac B. (Ed.). "Clinical Drug Investigation", (in Croatian.) Skolska Knjiga, Zagreb, 1984, pp 30-59.
7. Rocschlau P., Bernet E., Gruber N. Enzimatische Bestimmung des Gesamtcholesterins in Serum. (in German.) Z. Klin. Chem., 12, 403, 1974.
8. Wahlefelds A.W. Tryglicerides. Determination after enzymatic hydrolysis. In: Bermeyer H.U. (Ed.). "Methods of Enzymatic Analysis". Academic Press, New York-London, 1974, pp 1831-1835.
9. Kageyama N. A direct calorimetric determination of uric acid in serum and urine with uricase-catalase system. Clin. Chem. Acta, 31, 421, 1971.
10. Ivankovic D. The basic statistical analyses (in Croatian.) University of Zagreb School of Medicine, Zagreb, 1991, 370.
11. Tweeddale M.G., Ogilvie R.I., Ruedy J. Antihypertensive and biochemical effects of chlorthalidone. Clin. Pharmacol. Ther., 22, 519, 1977.
12. Verho M., Rangoonwala B., Dois W. Single and divided daily dose piretanide in the treatment of uncomplicated essential hypertension: a double-blind comparison with a combination of hydrochlorothiazide and amiloride. Eur. J. Clin. Pharmacol., 29, 269, 1985.
13. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. J.A.M.A., 265, 3255, 1991.
14. Report of the management committee. The Australian therapeutic trial in mild hypertension. Lancet, 1, 1261, 1980.
15. European Working Party on High Blood Pressure in the Eldery. Mortality and morbidity results from the European Work-ing Party on high blood pressure in the elderly. Lancet, 1, 1349, 1985.
16. Neaton J.D., Grimm R.H., Prineas R.J., et al. Treatment of mild hypertension study. J.A.M.A., 270, 713, 1993.
17. Moser M. Clinical trials and their effect on medical therapy: the multiple risk factor intervention trial. Am. Heart J., 107, 616, 1984.
18. Varden S., Mehrothra G.K., Mookherje S., Willsey G.A., Gens J.D., Green D.E. Efficacy and reduced metabolic side effects of a 15 mg chlorthalidone formulation in the treatment of mild hypertension. J.A.M.A., 258, 484, 1987.
19. Dupont A.G. The place of diuretics in the treatment of hypertension: a historical review of classical experience over 30 years. Cardiovasc. Drugs Ther, 7, 55, 1993.
20. 1993 Guidelines for the management of mild hypertension; memorandum from a WHO/ISH meeting. ISH Hypertension News, 3, 1993.
21. Bagatin J., Rumboldt Z., Jurišić M., et al. The importance of hypokalemia in diuretic-treated hypertensives. (in Croatian.) Pharmaca., 25, 175, 1987.
22. Moser M. In defense of traditional antihypertensive therapy. Hypertension, 12, 324, 1988.
23. Fries E.D. Critique of the clinical importance of diuretic-induced hypokalemia and elevated cholesterol level. Arch. Intern. Med., 149, 2640, 1989.
24. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Propranolol in the treatment of essential hypertension. J.A.M.A., 237, 2303, 1977.
25. Prichard B.N.C. Hypotension from B adrenergic blocking drugs. Am. Heart J., 69, 716, 1965.
26. Prichard B.N.C., Gillam P.M.S. Use of propranolol (inderal) in the treatment of hypertension. Br. Med. J., 2, 725, 1964.
27. Kostis J.B., Rosen R.C., Brondolo E., Taska L., Smith D., Wilson A.C. Superiority of nonpharmacologic therapy compared to propranolol and placebo in men with mild hypertension: a randomized, prospective trial. Am. Heart J., 123, 166, 1992.
28. Ames R.P. The effects of antihypertensive drugs on serum lipids and lipoproteins II. Non-diuretic drugs. Drugs, 32, 335, 1986.
29. Johnson B.F., Danylchuk MA The relevance of plasma lipid changes with cardiovascular drug therapy. Med. Clin. North Am., 73, 449, 1989.